VeriMompalmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine est-il sûr pendant la grossesse ?
Reviewed by VeriMom Editorial Team · Last reviewed
Ingrédients
palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
PAS DE RISQUES CONNUS100
/100
0
Pregnancy-safe products containing palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
Matte
Matte Growth Factor Serum
99/100
ISOMERS Skincare
ISOMERS Skincare Stemgenesis® Pur Orchid Concentrate
99/100
TAHNYC
TAHNYC Contour Concentrated 10 Peptide Serum
99/100
Basiclab
Basiclab Esteticus Antioxidant Compensating Serum With 20% Vitamin C
98/100
The Neo Mortal
The Neo Mortal Hand And Body Balm V6
98/100
Nécessaire
Nécessaire Hand Cream *2023 Update*
98/100
RevivSerums
RevivSerums Telomerase 6-In-1 Multi-Corrective Serum
98/100
Basiclab
Basiclab Esteticus Skin Structure Regenerating Serum with 1% Ceramides and 5% Peptides
98/100
Bigger Than Beauty
Bigger Than Beauty Light Weight Moisturizer
98/100
HighDroxy
HighDroxy Re:store Ageless
98/100
Related ingredients
À voir aussi
Sources & references
Authoritative references used to score this ingredient.
Frequently asked questions
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine est-il sûr pendant la grossesse ?
- No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine est-il sûr pendant l'allaitement ?
- No data indicating transfer into breast milk or lactation-related toxicity. Given the peptide's size/polarity and expected negligible systemic absorption after topical use, risk of exposure to breastfed infants is unlikely. No regulatory flags (ECHA Annex VI, SCCS, CIR) or peer‑reviewed evidence were found.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or toxicology data located. Adult dermal absorption is expected negligible; however, infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, so exposure score is increased by +1 for 0–3 yr. There is still no mechanistic or hazard evidence suggesting reproductive or developmental toxicity for infants.
- Comment VeriMom évalue-t-il palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine ?
- VeriMom évalue palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.